Other

UN nears landmark deal on combating biopiracy

The fight against biopiracy—plundering genetic resources and the traditional knowledge surrounding them—could soon be based on an international treaty which is being finalized at negotiations that began on Monday.

Diseases, Conditions, Syndromes

Chinese scientists ask for patent on US drug to fight virus

Scientists in the city at the center of China's virus outbreak have applied to patent a drug made by U.S. company Gilead Sciences Inc. to treat the disease, possibly fueling conflict over technology policy that helped trigger ...

Medications

Hepatitis C drug faces fresh battle

Medical groups mounted a new legal bid Monday to break a US pharma giant's hold on a hepatitis C drug whose price—costing thousands of dollars for a typical course—has unleashed a fierce patent battle.

Medications

Charity scores small win in Hep C drug battle

A medical charity scored a small victory Wednesday in its bid to break a US pharma giant's hold on an eye-wateringly expensive Hepatitis C drug when a European body partially revoked the firm's patent.

HIV & AIDS

HIV diagnostic kit wins European inventors prize

A rapid HIV diagnostic kit for developing nations, designed by Cambridge University researcher Helen Lee, won the Popular Prize at the European Inventor Awards on Thursday.

Diabetes

One step closer to curing diabetes

A human cell line genetically engineered to produce, store and release insulin in response to blood sugar levels in the human body could eliminate the need for daily injections for insulin-reliant diabetics.

Medications

French charity attacks Gilead patent for hepatitis drug

French charity Medecins du Monde (MdM) on Tuesday said it was contesting a European patent awarded to a hepatitis drug made by US firm Gilead Sciences, arguing the treatment was too costly.

page 1 from 3